表紙
市場調查報告書

焦慮症市場分析,規模,佔有率,趨勢,預測(2016-2027)-COVID-19更新:藥物分類,治療和地區

Anxiety Disorders Treatment Market, by drug category, therapy, and Geography - Analysis, Share, Trends, Size, & Forecast From 2016 - 2027- COVID- 19 Updated

出版商 AnalystView Market Insights 商品編碼 950988
出版日期 內容資訊 英文 206 Pages
商品交期: 2-3個工作天內
價格
焦慮症市場分析,規模,佔有率,趨勢,預測(2016-2027)-COVID-19更新:藥物分類,治療和地區 Anxiety Disorders Treatment Market, by drug category, therapy, and Geography - Analysis, Share, Trends, Size, & Forecast From 2016 - 2027- COVID- 19 Updated
出版日期: 2020年07月01日內容資訊: 英文 206 Pages
簡介

到2019年,全球焦慮和抑鬱治療市場預計將達到166億美元,增長率為2.2%。焦慮相關疾病的患病率增加,已增加了市場對採用市場上可用的各種療法的臨床緊迫性,並有望在未來幾年內加速增長,根據世界衛生組織(WHO)的調查,焦慮症和其他抑鬱症是最常見的精神障礙,影響全世界3億多人。該數字預計將在預測期內以恆定速度增長。

該報告對全球焦慮症治療市場進行了調查和分析,並提供了有關市場概況,市場規模和預測,按細分市場進行的市場分析,按地區進行的市場分析,競爭情況等系統信息。

焦慮症市場概述

  • 調查範圍
  • 基準年
  • 前提條件和調查方法

執行摘要

  • 主要市場數據
  • 區域情景
  • 進入市場的公司

焦慮症治療的主要市場趨勢

  • 促進市場增長的因素
  • 市場增長因素的影響分析
  • 市場增長制約因素
  • 影響市場增長的因素的影響分析
  • 市場機會
  • 市場的未來趨勢

焦慮症治療行業調查

  • 企業活動分析
  • 監管框架分析
  • 價值鏈分析

焦慮症市場趨勢

  • 市場佔有率分析
  • 主要創新者分析

按藥物類別劃分的焦慮症市場

  • 概述
  • 血清素再攝取抑製劑(SSRI)
    • 概述
    • 市場分析,預測,同比增長率(基於價值)
  • 三環抗抑鬱藥(TCA)
  • 5-羥色胺去甲腎上腺素再攝取抑製劑(SNRI)
  • 單胺氧化□抑製劑(MAOI)
  • 抗驚厥藥
  • 其他

治療焦慮症市場

  • 概述
  • 經顱磁刺激儀
    • 概述
    • 市場分析,預測,同比增長率(基於價值)
    • 電驚厥療法(ECT)
    • 認知行為療法(CBT)
    • Fisher Wallace刺激器
    • 其他

焦慮症治療市場:區域市場

  • 簡介
  • 北美
    • 概述
    • 市場分析,預測,同比增長率(基於價值)
  • 美國
  • 加拿大
  • 歐洲
  • 法國
  • 德國
  • 其他歐洲
  • 亞太(APAC)
  • 中國
  • 印度
  • 亞太地區其他國家
  • 其他地區
  • 拉丁美洲
  • 中東和非洲

供應商分析

  • Eli Lily&Company
    • 公司簡介
    • SWOT分析
    • 主要發展
  • Bristol-Myers Squibb Company
  • AstraZeneca plc
  • Johnson & Johnson
  • GlaxoSmithKline
  • Pfizer, Inc.

分析師的全方位視角

目錄

Title:
Anxiety Disorders Treatment Market, by drug category (SSRIs, TCAs, SNRIs, MAOIs, Anticonvulsants, and Others), therapy (TMS, ECT, CBT, FWS, and Others), and Geography (North America, Europe, Asia Pacific, And Rest Of The World) - Analysis, Share, Trends, Size, & Forecast From 2016 - 2027- COVID- 19 Updated.

SCOPE AND OBJECTIVES

The objective of this report is to describe the market trends and revenue forecasts for the ANXIETY DISORDER TREATMENT Market for the upcoming years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the coil coatings market. The scope of this report covers the ANXIETY DISORDER TREATMENT Market by its major segments, which include the type, end user industry, and the major geographic regions.

KEY BENEFITS OF THE REPORT:

  • Understanding of the strategies that are being adopted by the key players in this market to stay competitive
  • Extensive analysis of the key players dominating the competitive landscape of this market
  • In-depth analysis of the key factors are propelling the growth of the global market
  • Detailed analysis of the geographic region that will witness the strongest growth
  • Granular analysis of the current market scenario and the expected market grow

REPORT HIGHLIGHT

The anxiety disorders & depression treatment market is estimated to represent a global market of USD 16.6 billion by 2019 with growth rate of 2.2%.

Anxiety is defined as an excessive fear of a normal situation or an exaggerated response to a fear. Anxiety is one of the fast spreading disorder across the globe, majorly among young population. However, people often live with anxiety problem for years before they diagnose or treat with the condition which would in turn hamper the market growth to some extent. According to the American Psychiatric Association, anxiety can be categorized into phobias, acute stress disorder, panic disorder, obsessive-compulsive disorder, generalized anxiety disorder, and post-traumatic stress disorder.

Increasing prevalence of anxiety related disorders has led to high clinical urgency for adoption of various therapies and therapeutics available in the market, which is anticipated to fuel growth over the coming years. As per World Health Organization (WHO), anxiety and other form of depressions are one of the most common mental disorders affecting more than 300 million people worldwide. The number is projected to increase at constant rate during the forecast period.

COVID-19 IMPACT & Recovery Analysis

The proposed report from AnalystView Market Insights suggests three possible forecast scenarios (probable, optimistic, and pessimistic) considering the COVID-19 impact. Our ongoing research analysis amplifies our framework to ensure the inclusion of underlying COVID-19 crisis impact and potential paths forward. The designed report is delivering detailed insights on COVID-19 considering the changes in consumer demand, purchasing patterns, re-routing of the supply chain, and the significant interventions of governments. The updated study provides insights, and forecast, considering the COVID-19 impact on the market.

In terms of drug category, the market is divided into Selective Serotonin Reuptake Inhibitors (SSRIs), Tricyclic Antidepressants (TCAs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), Monoamine oxidase inhibitors (MAOIs), Anticonvulsants, and Others. Among which, SSRIs and SNRIs are contributed to largest market share, capturing almost 60% share of the global market. Furthermore, segments such as beta blockers, SSRIs and others are considered to be the highest growing market segment during the coming years. This upsurge is a consequence of high stress and competitive work environment coupled with unprecedented shift in the lifestyle, such as drinking, smoking, consumption of unhealthy food, etc.

Regionally, developed countries of North America and Europe dominated the market, captured more than 70% share of the global market. Boost in research and development activities by key operating companies to introduce novel anxiety therapeutics and therapies coupled with surge in demand for effective anxiety therapeutics among end-users drives the market growth.

Furthermore, large number of therapeutics under clinical investigation in North America & Europe further support the market growth. For example, Switzerland based Adde Therapeutics initiated multi-centric, double-blinded, Phase II tiral of ADX71149 in adults affected with major depressive disorder in collaboration with Janssen Pharmaceuticals, Inc. These types of initiatives will support the market growth to great extent.

The market size and forecast for each segment has been provided for the period 2016 to 2027, considering 2019 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2021 to 2027 for every reported segment.

The years considered for the study are:

  • Historical Year - 2016 to 2018
  • Base Year - 2019
  • Estimated Year - 2020
  • Projected Year - 2027

The proposed reports analyse and evaluates the COVID-19 impact, and anticipated change on the future market scenario on this industry, by taking into the account the economic, political, technological, and social, parameters.

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ANXIETY DISORDERS & DEPRESSION TREATMENT MARKET, BY DRUG CATEGORY

  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Tricyclic Antidepressants (TCAs)
  • Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
  • Monoamine oxidase inhibitors (MAOIs)
  • Anticonvulsants
  • Others

GLOBAL ANXIETY DISORDERS & DEPRESSION TREATMENT MARKET, BY THERAPY

  • Transcranial Magnetic Stimulator (TMS)
  • Electroconvulsive Therapy (ECT)
  • Cognitive Behaviour Therapy (CBT)
  • Fischer Wallace Stimulator
  • Others

GLOBAL ANXIETY DISORDERS & DEPRESSION TREATMENT MARKET, BY REGION

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

TABLE OF CONTENTS

ANXIETY DISORDER TREATMENT MARKET OVERVIEW

  • Study Scope
  • Base Year
  • Assumption and Methodology

EXECUTIVE SUMMARY

  • Key Market Facts
  • Geographical Scenario
  • Companies in the Market

ANXIETY DISORDER TREATMENT KEY MARKET TRENDS

  • Market Drivers
  • Impact Analysis of Market Drivers
  • Market Restraints
  • Impact Analysis of Market Restraints
  • Market Opportunities
  • Market Future Trends

ANXIETY DISORDER TREATMENT INDUSTRY STUDY

  • Company Activity Analysis
  • Regulatory Framework Analysis
  • Value Chain Analysis

ANXIETY DISORDER TREATMENT MARKET LANDSCAPE

  • Market Share Analysis
  • Key Innovators

ANXIETY DISORDER TREATMENT MARKET - BY DRUG CATEGORY:

  • Overview
  • Serotonin Reuptake Inhibitors (SSRIs)
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • Tricyclic Antidepressants (TCAs)
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • Monoamine oxidase inhibitors (MAOIs)
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • Anticonvulsants
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • Others
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)

ANXIETY DISORDER TREATMENT MARKET - BY THERAPY:

  • Overview
  • Transcranial Magnetic Stimulator
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • Electroconvulsive Therapy (ECT)
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • Cognitive Behaviour Therapy (CBT)
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • Fischer Wallace Stimulator
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • Others
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)

ANXIETY DISORDER TREATMENT MARKET- BY GEOGRAPHY

  • Introduction
  • North America
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • U.S.
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • Canada
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • Europe
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • France
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • Germany
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • Rest of Europe
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • Asia Pacific (APAC)
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • China
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • India
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • Rest of APAC
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • Rest of the World
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • Latin America
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • Middle East and Africa
    • Overview
    • Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)

KEY VENDOR ANALYSIS

  • Eli Lily & Company
    • Company Overview
    • SWOT Analysis
    • Key Developments
  • Bristol-Myers Squibb Company
    • Company Overview
    • SWOT Analysis
    • Key Developments
  • AstraZeneca plc
    • Company Overview
    • SWOT Analysis
    • Key Developments
  • Johnson & Johnson
    • Company Overview
    • SWOT Analysis
    • Key Developments
  • GlaxoSmithKline
    • Company Overview
    • SWOT Analysis
    • Key Developments
  • Pfizer, Inc.
    • Company Overview
    • SWOT Analysis
    • Key Developments

360 DEGREE ANALYSTVIEW

APPENDIX

  • Research Methodology
  • Abbreviations
  • Disclaimer
  • Contact Us

List of Tables

  • Table 1: List of Acronyms
  • Table 2: Key Market Facts, 2014 - 2025
  • Table 3: Market Drivers: Impact Analysis
  • Table 4: Market Restraint: Impact Analysis
  • Table 5: Market Opportunity: Impact Analysis
  • Table 6: PESTLE Analysis
  • Table 7: Porter's Five Forces Analysis
  • Table 8: Company Market Share Analysis
  • Table 9: Global Anxiety Disorder Treatments Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
  • Figure 10: Anxiety Disorder Treatments Market, by Drug Category, 2016 - 2027 (USD Million)
  • Figure 11: Anxiety Disorder Treatments Market, by Therapy, 2016 - 2027 (USD Million)
  • Figure 12: Anxiety Disorder Treatments Market, by Geography, 2016 - 2027 (USD Million)
  • Table 13: North America Anxiety Disorder Treatments Market, 2016 - 2027 (USD Million)
  • Table 14: U.S. Anxiety Disorder Treatments Market, 2016 - 2027 (USD Million)
  • Table 15: Canada Anxiety Disorder Treatments Market, 2016 - 2027 (USD Million)
  • Table 16: Europe Anxiety Disorder Treatments Market, 2016 - 2027 (USD Million)
  • Table 17: France Anxiety Disorder Treatments Market, 2016 - 2027 (USD Million)
  • Table 18: Germany Anxiety Disorder Treatments Market, 2016 - 2027 (USD Million)
  • Table 19: Asia Pacific Anxiety Disorder Treatments Market, 2016 - 2027 (USD Million)
  • Table 20: China Anxiety Disorder Treatments Market, 2016 - 2027 (USD Million)
  • Table 21: India Anxiety Disorder Treatments Market, 2016 - 2027 (USD Million)
  • Table 22: Latin America Anxiety Disorder Treatments Market, 2016 - 2027 (USD Million)
  • Table 23: MEA Anxiety Disorder Treatments Market, 2016 - 2027 (USD Million)

List of Figures

  • Figure 1: Research Methdology
  • Figure 2: Research Process Flow Chart
  • Figure 3: Comparative Analysis, by Geography, 2016-2025 (Value %)
  • Figure 4: Regulatory Framework Analysis
  • Figure 5: Value Chain Analysis Analysis
  • Figure 6: Anxiety Disorder Treatments Market, by Drug Category, 2016 - 2027 (USD Million)
  • Figure 6: Anxiety Disorder Treatments Market, by Therapy, 2016 - 2027 (USD Million)
  • Figure 7: Anxiety Disorder Treatments Market, by Geography, 2016 - 2027 (USD Million)